↓ Skip to main content

A Gut Feeling about GABA: Focus on GABAB Receptors

Overview of attention for article published in Frontiers in Pharmacology, January 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs
1 blog
twitter
9 tweeters
patent
1 patent
facebook
4 Facebook pages
wikipedia
4 Wikipedia pages
googleplus
1 Google+ user
reddit
1 Redditor

Citations

dimensions_citation
124 Dimensions

Readers on

mendeley
237 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Gut Feeling about GABA: Focus on GABAB Receptors
Published in
Frontiers in Pharmacology, January 2010
DOI 10.3389/fphar.2010.00124
Pubmed ID
Authors

Niall P. Hyland, John F. Cryan

Abstract

γ-Aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the body and hence GABA-mediated neurotransmission regulates many physiological functions, including those in the gastrointestinal (GI) tract. GABA is located throughout the GI tract and is found in enteric nerves as well as in endocrine-like cells, implicating GABA as both a neurotransmitter and an endocrine mediator influencing GI function. GABA mediates its effects via GABA receptors which are either ionotropic GABA(A) or metabotropic GABA(B). The latter which respond to the agonist baclofen have been least characterized, however accumulating data suggest that they play a key role in GI function in health and disease. Like GABA, GABA(B) receptors have been detected throughout the gut of several species in the enteric nervous system, muscle, epithelial layers as well as on endocrine-like cells. Such widespread distribution of this metabotropic GABA receptor is consistent with its significant modulatory role over intestinal motility, gastric emptying, gastric acid secretion, transient lower esophageal sphincter relaxation and visceral sensation of painful colonic stimuli. More intriguing findings, the mechanisms underlying which have yet to be determined, suggest GABA(B) receptors inhibit GI carcinogenesis and tumor growth. Therefore, the diversity of GI functions regulated by GABA(B) receptors makes it a potentially useful target in the treatment of several GI disorders. In light of the development of novel compounds such as peripherally acting GABA(B) receptor agonists, positive allosteric modulators of the GABA(B) receptor and GABA producing enteric bacteria, we review and summarize current knowledge on the function of GABA(B) receptors within the GI tract.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 237 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ireland 2 <1%
Netherlands 1 <1%
France 1 <1%
Korea, Republic of 1 <1%
Portugal 1 <1%
Australia 1 <1%
South Africa 1 <1%
Canada 1 <1%
United States 1 <1%
Other 0 0%
Unknown 227 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 60 25%
Researcher 39 16%
Student > Bachelor 37 16%
Student > Master 15 6%
Other 13 5%
Other 35 15%
Unknown 38 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 55 23%
Medicine and Dentistry 32 14%
Biochemistry, Genetics and Molecular Biology 30 13%
Neuroscience 21 9%
Pharmacology, Toxicology and Pharmaceutical Science 10 4%
Other 42 18%
Unknown 47 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2022.
All research outputs
#1,613,510
of 23,347,114 outputs
Outputs from Frontiers in Pharmacology
#566
of 16,822 outputs
Outputs of similar age
#7,510
of 166,199 outputs
Outputs of similar age from Frontiers in Pharmacology
#2
of 14 outputs
Altmetric has tracked 23,347,114 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,822 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,199 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.